By Ray Schneider, Chief Consulting Officer and Vice President, Tunnell Consulting Imagine a group of pharmaceutical manufacturing experts who convene to discuss the FDAs Process Analytical...
By Ray Schneider, Chief Consulting Officer and Vice President, Tunnell Consulting On-line and at-line testing could also reduce production cycle time. Reduced production cycle times would, in turn,...
Much has been made of Dr. Ajaz Hussains departure from FDAs process analytical technology (PAT) team; Hussain has moved on to become VP and global head of biopharmaceutical development for...
Excerpted remarks by Ajaz Hussain, VP of Development at Sandoz, at IFPAC 2007. An audio file of this excerpt can be heard by clicking the Download Now button beneath the text transcription. Please...
Operational Excellence & Lean Six Sigma FDA's Chief Medical Officer and Deputy Commissioner Janet Woodcock on the Critical Path, Quality by Design, risk-based compliance and where they all...